logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Navitor Pharmaceuticals, Inc.

USPTO Granted Patents = 18

% Expired Patents = 11.1



Forward Citations = 69

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Eddine Saiah (13 out of 33 patents)

silverMedal David John O'Neill (9 out of 16 patents)

bronzeMedal Sridhar Narayan (6 out of 12 patents)

4.  Kristina Michelle Fetalvero (5 out of 5 patents)

5.  Shomit Sengupta (5 out of 6 patents)

6.  Silvia Lenzini (3 out of 3 patents)

7.  Seong Woo Anthony Kang (3 out of 5 patents)

8.  George Vlasuk (3 out of 3 patents)

9.  Andrew Brearley (2 out of 2 patents)

10.  Jonathan Bentley (2 out of 13 patents)

11.  Steven D Targum (2 out of 2 patents)

12.  Sarah Mahoney (1 out of 1 patent)

13.  Lisa Molz (1 out of 1 patent)

14.  Steven Leventer (1 out of 1 patent)

15.  Steven Leventer (1 out of 1 patent)


18 patents:

1. 12465583 - Methods of treatment using an mTORC1 modulator (2025-11-11),
2. 12427130 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2025-09-30),
3. 12378263 - Modulators of sestrin-GATOR2 interaction and uses thereof (2025-08-05),
4. 12252456 - Polymorphic compounds and uses thereof (2025-03-18),
5. 11723890 - Methods of treatment using an mTORC1 modulator (2023-08-15),
6. 11697633 - Polymorphic compounds and uses thereof (2023-07-11),
7. 11679090 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2023-06-20),
8. 11345654 - Polymorphic compounds and uses thereof (2022-05-31),
9. 11339144 - Heteroaryl Rheb inhibitors and uses thereof (2022-05-24),
10. 11325924 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2022-05-10),
11. 10980784 - Rapamycin analogs and uses thereof (2021-04-20),
12. 10912750 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2021-02-09),
13. 10844013 - Phenyl amino piperidine mTORC inhibitors and uses thereof (2020-11-24),
14. 10752644 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2020-08-25),
15. 10683308 - Rapamycin analogs and uses thereof (2020-06-16),
Company Overview
Navitor Pharmaceuticals, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative therapeutics that harness the power of the immune system to treat a range of diseases. The company specializes in the discovery and advancement of small molecule drugs that target critical pathways in cellular signaling, particularly in the areas of oncology and immunology. By leveraging cutting-edge research and technology, Navitor aims to create transformative treatments that improve patient outcomes and address unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

18 Patents

#154 in Cambridge, MA

#1,102 in Massachusetts

#17,974 in US

#34,244 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Navitor Pharmaceuticals, Inc.

Forward Citations = 69

16 inventors:

goldMedal Eddine Saiah (13 out of 33 patents)

silverMedal David John O'Neill (9 out of 16 patents)

bronzeMedal Sridhar Narayan (6 out of 12 patents)

4.  Kristina Michelle Fetalvero (5 out of 5 patents)

5.  Shomit Sengupta (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Navitor Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/navitor-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…